A recombinant vaccinia-rabies virus in the immunocompromised host: Oral innocuity, progressive parenteral infection, and therapeutics

Vaccine

Volumn 15, Issue 2, 1997, Pages 140-148

  Hanlon, Cathleen A ^a,b   Niezgoda, Michael ^a,b   Shankar, Vidya ^a   Niu, Hong Shin ^a   Koprowski, Hilary ^a   Rupprecht, Charles E ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiviral therapy; Rabies vaccine; Severe combined immunodeficient mice; Vaccinia

Indexed keywords

CIDOFOVIR; IMMUNOGLOBULIN; RABIES VACCINE; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FEMALE; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABIES; SURVIVAL; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; FEMALE; INJECTIONS, INTRADERMAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, SCID; RABIES; RABIES VACCINES; RABIES VIRUS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC; VACCINIA; VACCINIA VIRUS; VIRAL VACCINES;

EID: 0031081377     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00163-6     Document Type: Article

References (66)

1. 1 Baer, G.M., Abelseth, M.K. and Debbie, J.G. Oral vaccination of foxes against rabies. Am. J. Epidemiol. 1971, 93, 487
2. 2 Rupprecht, C.E., Hanlon, C.A., Hamir, A. and Koprowski, H. Oral wildlife rabies vaccination: development of a recombinant virus vaccine. Transactions of the 57th North American Wildlife and Natural Resources Conference, Wildlife Management Institute, Washington, D.C. 1992, p. 439
3. 3 Winkler, W.G. and Bogel, K. Control of rabies in wildlife. Sci. Am. 1992, 266, 86
4. 4 Schneider, L.G., Cox, J.H., Muller, W.W. and Hohnsbeen, K.P. Current oral rabies vaccination: an interim balance. Rev. Infect. Dis. 1988, 10, S654
5. 5 Wandeler, A.I. Oral Immunization of Wildlife. In: Natural History of Rabies (Ed. Baer, G.M.). CRC Press, Inc., Boca Raton, FL, 1991, p. 485
6. 6 Krebs, J.W., Strine, T.W., Smith, J.S., Rupprecht, C.E. and Childs, J.E. Rabies surveillance in the United States during 1993. J. Am. Vet. Med. Assoc. 1994, 205, 1695
7. 7 Rupprecht, C.E., Wiktor, T.J., Johnston, D.H. et al. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine. Proc. Natl Acad. Sci. U.S.A. 1986, 83, 7947
8. 8 Rupprecht, C.E., Johnston, D.H., Hamir, A., Dietzschold, B. and Koprowski, H. Preliminary studies on the immunization and field baiting trials of raccoons against rabies. In: Vaccines '87 (Eds Chanock, R.M., Lerner, R.A. and Brown, F.). Cold Spring Harbor Laboratory, NY, 1987, p. 389
9. 9 Rupprecht, C.E. and Kieny, M.P. Development of a vaccinia-rabies glycoprotein recombinant rabies vaccine. In: Rabies: Developments in Veterinary Vaccines (Eds Campbell, J.B. and Charlton, K.M.). Kluwer Academic Publishers, Boston; 1988, p. 335
10. 10 Rupprecht, C.E., Dietzschold, B., Cox, J.H. and Schneider, L.G. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine. J. Wildl. Dis. 1989, 25, 548
11. 11 Kieny, M.P., Lathe, R., Drillien, R. et al. Expression of the rabies virus glycoprotein from a recombinant vaccinia virus. Nature 1984, 312, 163
12. 12 Rupprecht, C.E., Hamir, A.N., Johnston, D.H. and Koprowski, H. Efficacy of vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev. Infect. Dis. 1988, 10, S803
13. 13 Fox, J.L. Rabies vaccine field test-pending. Am. Soc. Micro. News 1989, 55, 355
14. 14 Blancou, J., Kieny, M.P., Lathe, R. et al. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature 1986, 332, 373
15. 15 Brochier, B., Kieny, M.P., Costy, F. et al. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine [see comments]. Nature 1991, 354, 520
16. 16 Rupprecht, C.E., Hanlon, C.A., Cummins, L.B. and Koprowski, H. Primate responses to a vaccinia-rabies glycoprotein recombinant virus vaccine. Vaccine 1992, 10, 368
17. 17 Buller, R.M.L., Smith, G.L., Cremer, K., Notkins, A.L. and Moss, B. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 1985, 317, 813
18. 18 Kaplan, C. Vaccinia virus: a suitable vehicle for recombinant vaccines?. Arch. Virol. 1989, 106, 127
19. 19 Moss, B. and Flexner, C. Vaccinia virus expression vectors. Ann. N.Y. Acad. Sci. 1989, 569, 86
20. 20 Conley, M.E. X-linked severe combined immunodeficiency. Clin. Immun. Immunopath. 1991, 61, S94
21. 21 Jones, J.F., Ritenbaugh, C.K., Spence, M.A. and Hayward, A. Severe combined immunodeficiency among the Navajo. I. Characterization of phenotypes, epidemiology, and population genetics. Human Biol. 1991, 63, 669
22. 22 Andrews, L.G. and Markert, M.L. Exon skipping in purine nucleoside phosphorylase mRNA processing leading to severe immunodeficiency. J. biol. Chem. 1992, 267, 7834
23. 23 Fischer, A. Severe combined immunodeficiencies, Immunodef. Rev. 1992, 3, 83
24. 24 Fenner, F. Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign. Res. Virol. 1989, 140, 465
25. 25 Bosma, M.J. and Carroll, A.M. The SCID mouse mutant: definition, characterization, and potential uses. A. Rev. Immun. 1991, 9, 323
26. 26 Wiktor, T.J., MacFarlan, R.I., Reagan, K.J. et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc. Natl Acad. Sci. U.S.A. 1984, 81, 7194
27. 27 Rupprecht, C.E., Charlton, K.M., Artois, M. et al. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccine for the striped skunk (Mephitis mephitis). J. Wildl. Dis. 1990, 26, 99
28. 28 Prevec, L., Campbell, J.B., Christie, B.S., Belbeck, L. and Graham, F.L. A recombinant human adenovirus vaccine against rabies. J. Infect. Dis. 1990, 161, 27
29. 29 Fenner, F., Henderson, D.A., Arita, I., Jezek, Z. and Ladnyi, I.D. Smallpox and its Eradication. World Health Organization, Geneva, Switzerland, 1988, p. 1421
30. 30 Winner, B.J. Statistical Principles in Experimental Design. McGraw-Hill, New York, 1971, p. 308
31. 31 Hsu, S.M., Raine, L. and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981, 29, 577
32. 32 Innis, M.A., Gelfand, D.H., Sninsky, J.J. and White, T.J. PCR Protocols. A Guide to Methods and Applications. Academic Press, Inc., San Diego, CA, 1990, p. 347
33. 33 Anilionis, A., Wunner, W.H. and Curtis, P.J. Amino acid sequence of the rabies virus glycoprotein deduced from its cloned gene. Comp. Immun. Micro. Infect. Dis. 1982, 5, 27
34. 34 Zar, J.H. Biostatistical Analysis. Prentice-Hall, Inc., Englewood Cliffs, NJ, 1974, p. 620
35. 35 Goldwasser, R.A. and Kissling, R.E. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc. Soc. Exp. Biol. Med. 1958, 98, 219
36. 36 Fenner, F. Poxviruses. In: Virology (Ed. Fields, B.N.). Raven Press, New York, 1985, p. 661
37. 37 Moss, B. Vaccinia virus vectors. Biotechnology 1992, 20, 345
38. 38 Redfield, R., Wright, D., James, W., Jones, T., Brown, C. and Burke, D. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N. Engl. J. Med. 1987, 316, 673
39. 39 Rabinovich, N.R., McInnes, P., Klein, D.L. and Hall, B.F. Vaccine technologies: view to the future. Science 1994, 265, 1401
40. 40 McGuill, M., Kreindel, S., DeMaria, A., et al. Human and domestic animal exposures to V-RG bait-vaccine units: the experience of Massachusetts and other U.S.A. States. 6th International Control of Rabies in the Americas Conference, 1995, Merida, Mexico
41. 41 Hanlon, C.A., Laniewicz, B., Willsey, A., et al. Capital region oral wildlife rabies vaccination: first evaluation in an enzootic area. Response to Wildlife Rabies: The Potential for Wildlife Rabies Vaccination, Albany, NY, 1995, p. 4
42. 42 Campbell, C.T. Human and domestic animal V-RG bait contacts in a New Jersey field trial. Fourth International Meeting, Advances towards Rabies Control in the Americas, Philadelphia, PA, 1993, p. 37
43. 43 Thomas, I., Brochier, B., Languet, B. et al. Primary multiplication site of the vaccinia-rabies glycoprotein recombinant virus administered to foxes by the oral route. J. Gen. Virol. 1990, 71, 37
44. 44 Charlton, K., unpublished data. FONSI. Veterinary biologics authorized field trial of an experimental biologic: the wistar Institute of Anatomy and Biology proposed field trial of a live experimental vaccinia vectored rabies vaccine. 1989, USDA, APHIS. Appendix IV
45. 45 Felsburg, P.J., Somberg, R.L. and Perryman, L.E. Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses. Immunodef. Rev. 1992, 3, 277
46. 46 Winkler, W.G., Shaddock, J.H. and Williams, L.W. Oral rabies vaccine: evaluation of its infectivity in three species of rodents. Am. J. Epidemiol. 1976, 104, 294
47. 47 Wandeler, A.I. Control of wildlife rabies: Europe. In: Rabies: Developments in Veterinary Virology (Eds Campbell, J.B. and Charlton, K.M.). Kluwer Academic Publishers, Boston, MA 1988, p. 365
48. 48 Bingham, J., Foggin, C.M., Gerber, H. et al. Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus). Vet. Record 1992, 131, 55
49. 49 DeClercq, E. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues. Int. J. Immunopharm. 1991, 1, 91
50. 50 DeClercq, E. and Holy, A. Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice. Antimicrob. Agents Chemo. 1991, 35, 701
51. 51 Andrew, M.E., Karupiah, G., Boyle, D.B. et al. Effects of vaccinia virus-expressed interleukin 2 on the immune system of sublethally irradiated mice. Microb. Path. 1991, 10, 363
52. 52 Flexner, C., Hugin, A. and Moss, B. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature 1987, 330, 259
53. 53 Karupiah, G., Blanden, R.V. and Ramshaw, I.A. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J. Exp. Med. 1990, 172, 1495
54. 54 Ramshaw, I.A., Andrew, M.E., Phillips, S.M., Boyle, D.B. and Coupar, B.E.H. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature 1987, 329, 545
55. 55 Kohonen-Corish, M.R.J., King, N.J.C., Woodhams, C.E. and Ramshaw, I.A. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-γ. Eur. J. Immun. 1990, 20, 157
56. 56 Tartaglia, J., Perkus, M.E., Taylor, J. et al. NYVAC: a highly attenuated strain of vaccinia virus. Virology 1992, 188, 217
57. 57 Andrew, M.E., Coupar, B.E. and Boyle, D.B. Humoral and cell-mediated immune responses to recombinant vaccinia viruses in mice. Immun. Cell Biol. 1989, 67, 331
58. 58 Anonymous. Report of the Fifth Consultation on oral Immunization of Dogs Against Rabies. World Health Organization, Geneva, Switzerland, 1994
59. 59 Esposito, J.J., Knight, J.C., Shaddock, J.H., Novembre, F.J. and Baer, G.M. Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein. Virology 1988, 165, 313
60. 60 Wandeler, A.I., Capt, S., Kappeier, A. and Hauser, R. Oral immunization of wildlife against rabies: concept and first field experiments. Rev. Infect. Dis. 1987, 10, S649
61. 61 LeBlois, H., Tuffereau, C., Blancou, J., Artois, M., Aubert, A. and Flamand, A. Oral immunization of foxes with avirulent rabies virus mutants. Vet. Microbiol. 1990, 23, 259
62. 62 Coulon, P., Lafay, F., Benejean, J. and Flamand, A. New vaccinal strains for oral vaccination. Fourth International Meeting, Advances towards Rabies Control in the Americas, 1993, Philadelphia, PA, USA, p. 28
63. 63 Foley, P.L., Paul, P.S., Levings, R.L., Hanson, S.K. and Middle, L.A. Swinepox virus as a vector for the delivery of immunogens. Ann. N.Y. Acad. Sci. 1991, 646, 220
64. 64 Taylor, J., Weinberg, R., Tartaglia, J. et al. Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins. Virology 1992, 187, 321
65. 65 Taylor, J., Trimarchi, C., Weinberg, R. et al. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine 1991, 9, 190
66. 66 Tartaglia, J., Cox, W.I., Taylor, J. et al. Highly attenuated poxvirus vectors. AIDS Res. Human Retrovir. 1992, 8, 1445